• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION; CORONARY DRUG ELUDING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION; CORONARY DRUG ELUDING STENT Back to Search Results
Catalog Number SEE MODEL NO.
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 06/29/2021
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
In context of the dapt study an orsiro mission drug eluting stent system was selected for treatment.The patient experienced retrosternal pain with radiation to the left arm on the night of (b)(6) 2021.After 45 minutes, patient was symptom free again.Patient had a scheduled cardiological control on (b)(6).During the check-up the ecg showed st elevations and a troponin elevation.Immediate transfer to the hospital for coronary angiography with suspected stent thrombosis.On (b)(6) 2021 a coronary angiography due to suspected stent thrombosis was done but no changes to previous angiography.Site assumes a passive stent thrombosis which has been completely recanalized in the meantime.Lot number unknown.
 
Manufacturer Narrative
Combination product: yes three months after the successful elective coronary treatment the patient developed myocardial infarction (mi) due to transient late stent thrombosis which was not evident anymore by coronary angiography at the time of readmission at the hospital.The clinical event committee rated the occurrence as spontaneous mi without vessel obstruction and probably resolved stent thrombosis.The review of the product release documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the provided documentation no device deficiency or manufacturing related root cause could be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION
Type of Device
CORONARY DRUG ELUDING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key12236285
MDR Text Key263810409
Report Number1028232-2021-04214
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/28/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? No
Date Manufacturer Received10/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-